Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,803
Recruiting: 1,544
Ph III recruiting: 175
Growth YoY: +16.5%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 51–100 of 383 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06029036	A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer	unknown	Phase 2	53	Peking University First HospitalOTHER	1	Dec 12, 2023	clinicaltrials
NCT06161272	Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi	unknown	Phase 2	80	Guangxi Medical UniversityOTHER	1	Dec 7, 2023	clinicaltrials